Tyra Biosciences, Inc. · NASDAQ:TYRA
BVF PARTNERS L P/IL's stake in Tyra Biosciences, Inc. fell to 4.00% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
BVF PARTNERS L P/IL's stake in Tyra Biosciences, Inc. fell to 4.00%, 2,127,665 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 4.00%
- Shares
- 2,127,665
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 2.10% | 1,135,053 |
| BVF I GP LLC | 2.10% | 1,135,053 |
| BIOTECHNOLOGY VALUE FUND II LP | 1.60% | 829,908 |
| BVF II GP LLC | 1.60% | 829,908 |
| Biotechnology Value Trading Fund OS LP | 0.20% | 130,502 |
| BVF Partners OS Ltd. | 0.20% | 130,502 |
| BVF GP HOLDINGS LLC | 3.70% | 1,964,961 |
| BVF PARTNERS L P/IL | 4.00% | 2,127,665 |
| BVF INC/IL | 4.00% | 2,127,665 |
| LAMPERT MARK N | 4.00% | 2,127,665 |
Source
Related
- Tyra Biosciences, Inc.
- Bvf Partners L P
- Tyra Biosciences, Inc. shareholders
- Schedule 13G · Bvf Partners L P · Sep 21, 2026
- Schedule 13G/A · Bvf Partners L P · Feb 14, 2025
- Form 4 · Harris Todd · Sep 17, 2026
- Form 4 · Rueb Yuliya · Sep 17, 2026
- Form 4 · Fuhrman Alan · Sep 17, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Sep 17, 2026
- Schedule 13G · Paradigm Biocapital Advisors LP · Sep 17, 2026